Committee for Orphan Medicinal Products (COMP): 10-12 May 2022
Date:
10/05/2022 to 12/05/2022
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Agenda of the COMP meeting 10-12 May 2022 (PDF/295.75 KB)
Draft
First published: 11/05/2022
EMA/COMP/262112/2022 -
List item
COMP meeting report on the review of applications for orphan designation: May 2022 (PDF/184.29 KB)
First published: 19/05/2022
EMA/COMP/272969/2022 -
List item
Minutes of the COMP meeting on 10-12 May 2022 (PDF/517.18 KB)
First published: 21/07/2022
EMA/COMP/260156/2022